Mitchell P. Kopin 13D and 13G filings for Titan Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-11-09 06:04 am Purchase | 2020-10-30 | 13G | Titan Pharmaceuticals, Inc. TTNP | Mitchell P. Kopin | 6 0.001% | 6 (New Position) | Filing |